自由基在肿瘤促进中的作用。
The role of free radicals in tumor promotion.
作者信息
Goldstein B D, Czerniecki B, Witz G
机构信息
Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854-5635.
出版信息
Environ Health Perspect. 1989 May;81:55-7. doi: 10.1289/ehp.898155.
Abstract
A role has been suggested for free radicals and active states of oxygen in tumor promotion. There are a number of lines of support for this hypothesis, but no definitive evidence. The hypothesis has proven of value in leading to the development of models pertinent to understanding the mechanism of action of tumor promoters.
摘要
自由基和活性氧状态在肿瘤促进过程中的作用已被提出。有许多支持这一假说的线索，但尚无确凿证据。这一假说已被证明在推动与理解肿瘤促进剂作用机制相关的模型发展方面具有价值。
相似文献
1
The role of free radicals in tumor promotion.自由基在肿瘤促进中的作用。
Environ Health Perspect. 1989 May;81:55-7. doi: 10.1289/ehp.898155.
2
The role of free oxygen radicals in tumor promotion and carcinogenesis.
Carcinog Compr Surv. 1982;7:593-7.
3
Oxidative stress and experimental carcinogenesis.氧化应激与实验性致癌作用
Indian J Exp Biol. 2002 Jun;40(6):656-67.
4
The role of oxygen radicals as a possible mechanism of tumor promotion.氧自由基作为肿瘤促进可能机制的作用。
Annu Rev Pharmacol Toxicol. 1985;25:509-28. doi: 10.1146/annurev.pa.25.040185.002453.
5
Role of free radicals in tumor promotion and progression.自由基在肿瘤促进和进展中的作用。
Prog Clin Biol Res. 1989;298:233-48.
6
Alcohol-associated generation of oxygen free radicals and tumor promotion.酒精相关的氧自由基生成与肿瘤促进作用。
Alcohol Alcohol. 1993 Nov;28(6):621-8.
7
Do tumor promoters affect DNA after all?
Science. 1983 Jan 14;219(4581):158-9. doi: 10.1126/science.6849126.
8
Protease inhibitors interfere with the necessary factors of carcinogenesis.蛋白酶抑制剂会干扰致癌作用的必要因素。
Environ Health Perspect. 1989 May;81:59-62. doi: 10.1289/ehp.898159.
9
Screening for skin-tumor promoters.皮肤肿瘤启动子的筛选。
Biomed Pharmacother. 1988;42(7):447-50.
10
引用本文的文献
1
Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders.截断变异在 SHANK1 基因中与一系列神经发育障碍有关。
Genet Med. 2021 Oct;23(10):1912-1921. doi: 10.1038/s41436-021-01222-w. Epub 2021 Jun 10.
2
Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11.杂合功能丧失变异显著扩展了与 GDF11 丧失相关的表型。
Genet Med. 2021 Oct;23(10):1889-1900. doi: 10.1038/s41436-021-01216-8. Epub 2021 Jun 10.
3
Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease.鉴定 Charcot-Marie-Tooth 病中的新型致病性拷贝数变异。
J Hum Genet. 2020 Mar;65(3):313-323. doi: 10.1038/s10038-019-0710-5. Epub 2019 Dec 18.
4
The copy number variation landscape of congenital anomalies of the kidney and urinary tract.先天性肾和泌尿道畸形的拷贝数变异景观。
Nat Genet. 2019 Jan;51(1):117-127. doi: 10.1038/s41588-018-0281-y. Epub 2018 Dec 21.
5
Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies.临床外显子组测序揭示了黏连蛋白病的基因座异质性和表型变异性。
Genet Med. 2019 Mar;21(3):663-675. doi: 10.1038/s41436-018-0085-6. Epub 2018 Aug 30.
6
Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study.生殖因素、激素使用与胃癌风险：新加坡华人健康研究。
Int J Cancer. 2016 Jun 15;138(12):2837-45. doi: 10.1002/ijc.30024. Epub 2016 Mar 10.
7
Association of adenosine deaminase, superoxide dismutase, and catalase activities with Helicobacter pylori.腺苷脱氨酶、超氧化物歧化酶和过氧化氢酶活性与幽门螺杆菌的关联
Dig Dis Sci. 2005 Dec;50(12):2296-9. doi: 10.1007/s10620-005-3050-6.
8
Gender-related regional antioxidant profiles in the gastrointestinal tract of the rat.大鼠胃肠道中与性别相关的区域抗氧化剂概况。
Mol Cell Biochem. 1996 Feb 9;155(1):43-9. doi: 10.1007/BF00714332.
9
Nasal cytology in southwest metropolitan Mexico City inhabitants: a pilot intervention study.墨西哥城西南部大都市居民的鼻腔细胞学：一项试点干预研究。
Environ Health Perspect. 1993 Jun;101(2):138-44. doi: 10.1289/ehp.101-1519752.
10
Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.胃癌、溃疡和萎缩性胃炎患者胃液中腺苷脱氨酶、5'-核苷酸酶、黄嘌呤氧化酶、超氧化物歧化酶和过氧化氢酶的活性。
Dig Dis Sci. 1994 Apr;39(4):721-8. doi: 10.1007/BF02087413.
本文引用的文献
1
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.皮肤肿瘤促进机制的研究：促进过程中多个阶段的证据
Proc Natl Acad Sci U S A. 1980 Jun;77(6):3659-63. doi: 10.1073/pnas.77.6.3659.
2
Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters.肿瘤启动子对人多形核白细胞超氧阴离子自由基产生的刺激作用。
Cancer Lett. 1981 Jan;11(3):257-62. doi: 10.1016/0304-3835(81)90117-8.
3
Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor promoters.维甲酸对肿瘤启动子刺激的人多形核白细胞产生超氧阴离子自由基的抑制作用。
Biochem Biophys Res Commun. 1980 Dec 16;97(3):883-8. doi: 10.1016/0006-291x(80)91459-x.
4
Tumorigenesis in mouse skin: inhibition by synthetic inhibitors of proteases.小鼠皮肤中的肿瘤发生：蛋白酶合成抑制剂的抑制作用
Science. 1970 Sep 18;169(3951):1211-3. doi: 10.1126/science.169.3951.1211.
5
Phorbol diacetate inhibits superoxide anion radical production and tumor promotion by mezerein.佛波醇二乙酸酯抑制了由狼毒素诱导的超氧阴离子自由基生成和肿瘤促进作用。
Carcinogenesis. 1986 Oct;7(10):1637-41. doi: 10.1093/carcin/7.10.1637.
6
Prooxidant states and tumor promotion.促氧化剂状态与肿瘤促进作用。
Science. 1985 Jan 25;227(4685):375-81. doi: 10.1126/science.2981433.
7
8
Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption.蛋白酶抑制剂可拮抗多形核白细胞氧消耗的激活。
Biochem Biophys Res Commun. 1979 Jun 13;88(3):854-60. doi: 10.1016/0006-291x(79)91487-6.
Zotero 插件